ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø¹ØÓÚÈ«×Ê×Ó¹«Ë¾Í¨¹ýÃÀ¹úFDAÏÖ³¡¼ì²éµÄͨ¸æ-ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø-ÐÂÎŶ¯Ì¬

ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø

ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø
ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø
EN
Ê×Ò³ / ÐÐÒµÐÂÎÅ

ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø¹ØÓÚÈ«×Ê×Ó¹«Ë¾Í¨¹ýÃÀ¹úFDAÏÖ³¡¼ì²éµÄͨ¸æ

ÃÀ²â2025Äê02ÔÂ25ÈÕ

±¾¹«Ë¾¼°¶­Ê»áÈ«Ìå³ÉÔ±°ü¹ÜÐÅÏ¢Åû¶ÄÚÈݵÄÕæÊµ¡¢×¼È·ºÍÍêÕû £¬Ã»ÓÐÐéα¼Í¼¡¢Îóµ¼ÐÔ³ÂÊö»òÖØ´óÒÅ©¡£

Õã½­ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°¹«Ë¾¡±£©È«×Ê×Ó¹«Ë¾Ì¨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÒ©ÒµÓÐÏÞ¹«Ë¾£¨ÒÔϼò³Æ¡°Ì¨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø¡±£©ÓÚ2024Äê11ÔÂ11ÈÕ-15ÈÕ½ÓÊÜÁËÀ´×ÔÃÀ¹úʳÎïÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£¨ÒÔϼò³Æ¡°FDA¡±£©µÄ cGMP£¨ÏÖÐÐÒ©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶£©ÏÖ³¡¼ì²é¡£¿ËÈǪ̃ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÊÕµ½FDA³ö¾ßµÄÏÖ³¡¼ì²é±¨¸æ£¨EIR £¬Establishment Inspection Report£© £¬Æ¾Ö¤ÃÀ¹ú21CFR ¹æÔò£¨ÃÀ¹úÁª°î¹æÔòµÚ21Õ£©µÄ»®¶¨ £¬FDAÈ·Èϱ¾´Î¼ì²éÒÑ¿¢Ê £¬Ì¨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÍ¨¹ý±¾´ÎÏÖ³¡¼ì²é¡£ÏÖ½«Ïà¹ØÐÅϢͨ¸æÈçÏ£º

Ò»¡¢FDAÏÖ³¡¼ì²éµÄÏà¹ØÐÅÏ¢

¹«Ë¾Ãû³Æ£ºÌ¨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÒ©ÒµÓÐÏÞ¹«Ë¾

Éú²úµØÖ·£ºÕ㽭ʡ̨ÖÝÊÐÁÙº£ÊÐÕ㽭ͷß۾­¼Ã¿ª·¢Çø¶«º£µÚËÄ´óµÀ3ºÅ

FDA FEI£º3012045665

¼ì²éʱ¼ä£º2024 Äê11ÔÂ11ÈÕ-15ÈÕ

¼ì²éÀàÐÍ£ºÒ»Ñùƽ³£î¿Ïµ¼ì²é

¼ì²é¹æÄ££ºÂÞ¿âäåï§¡¢Î¬¿âäåï§¡¢ÆÃÄáËÉ¡¢Ç⻯¿ÉµÄËɵÈÖÊÁÏÒ©

¼ì²éЧ¹û£ºNAI£¨No Action Indicated£©
¶þ¡¢¶Ô¹«Ë¾µÄÓ°Ï켰Σº¦ÌáÐÑ
±¾´Î¼ì²éµÄͨ¹ý £¬Åúע̨ÖÝÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍøÖÊÁ¿ÏµÍ³ÇкÏÃÀ¹úFDAÒªÇó £¬Îª¹«Ë¾Ò»Á¬ÍØÕ¹¹ú¼ÊÊг¡ÌṩÁ˼áʵµÄ°ü¹Ü £¬Ìá¸ßÁ˹«Ë¾ÖÊÁÏÒ©²úÆ·µÄ¹ú¼ÊÊг¡¾ºÕùÁ¦ £¬¶ÔÌáÉý¹«Ë¾×ۺϾºÕùÁ¦¼°Î´À´Éú³¤ÓÐ×ÅÆð¾¢µÄÍÆÐж¯Óá£

ÓÉÓÚÒ½Ò©²úÆ·µÄÐÐÒµÌØµã £¬¹ú¼ÊÖÊÁÏÒ©ÓªÒµÒ×ÊÜÍâÑóÊг¡ÇéÐÎת±ä¡¢ÐÐÒµÕþ²ß¡¢¹©Çó¹ØÏµµÈÒòËØÓ°Ïì £¬¾ßÓÐÒ»¶¨µÄ²»È·¶¨ÐÔ¡£¾´Çë¿í´óͶ×ÊÕßÀíÐÔͶ×Ê £¬×¢ÖØÍ¶×ÊΣº¦¡£


ÌØ´Ëͨ¸æ¡£



ÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¼¯ÍŹÙÍø

¶­Ê»á

2025Äê2ÔÂ20ÈÕ
ÍøÕ¾µØÍ¼